Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover the patented immobilized catalyst method for N,N-diallyl-5-methoxytryptamine hydrochloride. Achieve high purity and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN102503842B details amino alkoxy curcumin derivatives enhancing solubility and anti-tumor activity for cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104193749A reveals a one-pot synthesis for antineoplastic isatin derivatives. This report analyzes cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN105348063A reveals a novel synthesis method for Paeonol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113527168B reveals a novel acid-base extraction method for Vildagliptin, achieving over 90% yield and controlling disubstituted impurities below 0.1% without repeated recrystallization.
Novel phthalimide route for brexpiprazole intermediate offers high purity and yield, significantly reducing costs for API manufacturers.
Novel vanadium catalyst method for heterocyclic amides. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing. Enhances purity and scalability.
Novel synthesis route for Vb compound avoids palladium and butyllithium ensuring high purity and cost reduction for pharmaceutical intermediates manufacturing supply chain.
Patent CN108752232B details a green photocatalytic method for alpha-quaternary amino acids using CO2, offering safer alternatives to toxic Strecker reactions for pharma supply chains.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN104178540B reveals a high-yield E. coli biocatalysis route for Ademetionine, offering superior purity and streamlined manufacturing for global supply chains.
Novel Pictet-Spengler and Heck coupling strategy enables scalable production of anti-inflammatory alkaloid Arbornamine with improved cost efficiency.
Patent CN104860867B details Mn-catalyzed synthesis offering high yields. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN115385909A details a novel Pd/Cu method for imidazophenanthridines, offering mild conditions and high purity for pharmaceutical intermediates.
Patent CN110563623A reveals a novel L-(+)-selenomethionine synthesis using selenium powder. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108059621A details anhydrous butanone purification for 5-Methylpyrazine-2-Carboxylic Acid ensuring high purity and yield for reliable pharmaceutical intermediate supply chains.
Novel Ru-catalyzed asymmetric hydrogenation process for TAFIa inhibitor intermediates. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN105753844A reveals convergent synthesis for Daclatasvir intermediates improving yield and atom economy. Discover supply chain advantages and cost reduction strategies.
Patent CN104220406A reveals novel nickel catalysis for hydroxyphenylcyclohexanol. Delivers high purity, reduced costs, and scalable supply chain solutions for global pharmaceutical manufacturers.
Novel patent CN116478155A enables high-purity Grapiprant production with significant cost reduction and supply chain reliability for veterinary pharmaceutical manufacturers.